Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-09 19:32:13 - browse：24915

The headquarter of Biotechnology company Ionis Pharmaceuticals, consists of glass windows, pale yellow exteriors and plants outside the building — biotech coverage from STAT — courtesy Ionis Pharmaceuticals

Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on Friday that a pair of late-stage trials showed that its experimental therapy for hereditary angioedema benefitted patients — including those taking drugs currently on the market.

In one of the Phase 3 trials, dubbed OASIS, patients with hereditary angioedema, a rare disease characterized by severe bouts of swelling, were given injections of donidalorsen either monthly or every two months. Those in the former group had an 81% lower monthly rate of swelling attacks after 25 weeks than patients given a placebo, while the reduction compared to placebo was 55% for those treated every two months.

The other study, OASISplus, found that donidalorsen’s benefits deepened and converged after up to an additional year of treatment, with swelling attack rates dropping by 92% to 93% regardless of how often patients were dosed. Notably, this study also tracked patients who switched over to donidalorsen from existing therapies meant to prevent swelling attacks, including drugs sold by Takeda and BioCryst Pharmaceuticals. Patients who switched to the Ionis drug saw their swelling attack rates drop by 62% compared to previous treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Dobbs anniversary: the lost opportunity of abortion as health care

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Intellia plays down concerns on accidental germline transmission

Republicans love RFK Jr. What's that tell us about health in 2024?

State Dept. review finds Biden bears some blame for Afghanistan failures

Virginia high school admissions case could be legal follow

California store owner shot dead in dispute over displaying Pride flag: Police

knowledge

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Meadows told special counsel he could not recall Trump ever declassifying Mar

Jerome Adams on the need for new antivirals for Covid

DeSantis wants to import drugs. Biden’s FDA blasted his plan

How to save PrEP access — and even expand it

In age of alternative facts, a scholarly course on calling out crap

How to save PrEP access — and even expand it

Guidelines to prevent youth baseball injuries need more muscle

23andMe had bad news about my health. I wish a person had delivered it

How the first Native Hawaiian psychiatrist helped diversify medicine

focus

FDA advisory panel to debate high blood pressure devices

What does generative AI mean for health care? We asked experts

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

At least 13 dead in Texas as scorching temps continue

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Jerome Adams on the need for new antivirals for Covid

hotspot

entertainment

Wikipedia

focus